DUPONT CAPITAL MANAGEMENT CORP - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 135 filers reported holding ANIKA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$348,000
-59.2%
12,024
-26.9%
0.01%
-57.9%
Q4 2019$853,000
-5.5%
16,4550.0%0.02%
-9.5%
Q3 2019$903,000
+102.5%
16,455
+49.9%
0.02%
+110.0%
Q2 2019$446,000
+34.3%
10,9740.0%0.01%
+25.0%
Q1 2019$332,000
-10.0%
10,9740.0%0.01%
-11.1%
Q4 2018$369,000
-64.0%
10,974
-47.1%
0.01%
-60.9%
Q2 2017$1,024,000
-16.7%
20,764
-26.6%
0.02%
-14.8%
Q1 2017$1,229,000
-13.2%
28,286
-2.2%
0.03%
-15.6%
Q4 2016$1,416,000
+10.8%
28,929
+8.3%
0.03%
+10.3%
Q3 2016$1,278,000
-44.6%
26,709
-37.9%
0.03%
-43.1%
Q2 2016$2,308,000
+20.0%
43,0170.0%0.05%
+15.9%
Q1 2016$1,924,000
+1.3%
43,017
-13.6%
0.04%
-4.3%
Q4 2015$1,899,000
+19.9%
49,7650.0%0.05%
+15.0%
Q3 2015$1,584,000
-3.6%
49,7650.0%0.04%
+11.1%
Q2 2015$1,644,000
-19.8%
49,7650.0%0.04%
-10.0%
Q1 2015$2,049,000
+1.1%
49,7650.0%0.04%
+8.1%
Q4 2014$2,027,000
+10.3%
49,765
-0.7%
0.04%
+15.6%
Q3 2014$1,837,000
-20.9%
50,1050.0%0.03%
-15.8%
Q2 2014$2,321,000
+9.2%
50,105
-3.1%
0.04%
+11.8%
Q1 2014$2,125,000
-12.3%
51,695
-18.6%
0.03%
-19.0%
Q4 2013$2,424,000
+38.0%
63,513
-13.4%
0.04%
+31.2%
Q3 2013$1,757,000
+12.9%
73,350
-19.8%
0.03%
+10.3%
Q2 2013$1,556,00091,5150.03%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
HealthInvest Partners AB 490,331$21,928,00010.27%
CAPITAL MANAGEMENT CORP /VA 211,660$9,465,0003.66%
AMI ASSET MANAGEMENT CORP 336,791$15,061,0001.03%
Baltimore-Washington Financial Advisors, Inc. 68,785$3,076,0000.93%
Portolan Capital Management 130,939$5,856,0000.78%
Kalos Management, Inc. 19,254$861,0000.72%
DIKER MANAGEMENT LLC 32,965$1,474,0000.56%
THOMPSON SIEGEL & WALMSLEY LLC 1,526,244$68,253,0000.56%
NEW AMSTERDAM PARTNERS LLC/NY 108,260$4,841,0000.51%
Boston Trust Walden Corp 493,780$22,082,0000.38%
View complete list of ANIKA THERAPEUTICS INC shareholders